A multicenter randomized phase II study of NPC-1C (N) in combination with gemcitabine (G) and nab-paclitaxel (A) versus G and A alone in patients with metastatic or locally advanced pancreatic cancer (PC) previously treated with folfirinox (F).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Duffy, AG; Beg, MS; Greten, TF; Beatson, MA; Mavroukakis, S; Patel, SP; Morse, MA; Arlen, PM

Published Date

  • January 20, 2015

Published In

Volume / Issue

  • 33 / 3_suppl

Start / End Page

  • TPS499 - TPS499

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2015.33.3_suppl.tps499